3-Year Check-In for CAD-POAF Study
Part of Heart & circulation clinical trials.
This study checks in on people who already joined the pCAD-POAF trial to see how they are doing after 3 years. It is a follow-up to learn more about long-term health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been a participant in the earlier pCAD-POAF study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a hospital-based study that collects standardized information about adults with specific heart conditions—heart failure, coronary artery disease, or atrial fibrillation. It may help doctors and researchers better understand these diseases and improve future care.
This trial is looking at what happens after a heart procedure called catheter ablation for atrial fibrillation (an irregular heartbeat). It mainly collects follow-up outcomes to better understand recovery and results for patients.
This study is testing a new computer program that helps doctors see if you have coronary artery disease (blockages in the heart's blood vessels). It looks back at past CT scans of the heart to see if the software works well compared to other tests.
This study looks at new care plans (“care pathways”) and how well they work, including cost and health outcomes. It may help by comparing whether a different follow-up approach after a new atrial fibrillation diagnosis leads to better care, especially for older adults.
This study looks at early changes in the heart related to atrial fibrillation (AF) using health data and biomarkers. It aims to find better ways to predict or understand AF, especially around procedures like ablation or cardioversion.
This study tests whether continuous heart-rhythm monitoring with a smartwatch can better guide treatment for atrial fibrillation (AF) while you stay on a blood thinner. The goal is to improve safety and reduce stroke risk by catching AF patterns more closely.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.